COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have had COVID-19.

This monocentric study is aimed at 3 types of patients:

• Those who have been hospitalized for Covid-19 during the epidemic
• Newly infected and diagnosed patients Covid-19
• Those with paucisymptomatic Covid-19 who did not require hospitalisation

At the patient's inclusion, an ophthalmologic assessment will be performed including :

• visual acuity,
• SD-OCT + multicolor,
• OCT-A,
• color retinography,

Fundus examination, optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in all COVID-19 patients may detect retinal lesions. In addition, if a correlation is demonstrated between clinical and paraclinical parameters and between disease severity and retinal vascular damage in non-invasive imaging (OCT and OCTA), this would allow a better understanding of the pathophysiology of the disease, as well as factors that may influence disease severity and the mechanisms potentially responsible for the observed disorders.

Inclusion Criteria:

• Age ≥ 18 years old
• Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan
• Affiliation to the general social security system
• A consent signed by the patient

Exclusion Criteria:

- Refusal of patient participation